These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18782902)

  • 21. Risk functions for prediction of cardiovascular disease in elderly Australians: the Dubbo Study.
    Simons LA; Simons J; Friedlander Y; McCallum J; Palaniappan L
    Med J Aust; 2003 Feb; 178(3):113-6. PubMed ID: 12558481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.
    Hero C; Svensson AM; Gidlund P; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K
    Diabet Med; 2016 Mar; 33(3):316-23. PubMed ID: 26498834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiovascular disease risk in diabetes patients aged 40 years old and above in China].
    Li JX; Li Y; Liu FC; Chen JC; Cao J; Chen SF; Hu DS; Shen C; Huang JF; Lu XF; Gu DF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Nov; 48(11):968-974. PubMed ID: 33210870
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients With Diabetes Mellitus.
    Liu G; Li Y; Hu Y; Zong G; Li S; Rimm EB; Hu FB; Manson JE; Rexrode KM; Shin HJ; Sun Q
    J Am Coll Cardiol; 2018 Jun; 71(25):2867-2876. PubMed ID: 29929608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Hanssen NMJ; Westerink J; Scheijen JLJM; van der Graaf Y; Stehouwer CDA; Schalkwijk CG;
    Diabetes Care; 2018 Aug; 41(8):1689-1695. PubMed ID: 29784769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
    Agca R; Hopman LHGA; Laan KJC; van Halm VP; Peters MJL; Smulders YM; Dekker JM; Nijpels G; Stehouwer CDA; Voskuyl AE; Boers M; Lems WF; Nurmohamed MT
    J Rheumatol; 2020 Mar; 47(3):316-324. PubMed ID: 31092721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study.
    Anderson JH; Anderson KR; Aulie HA; Crowson CS; Mason TG; Ardoin SP; Reed AM; Flatø B
    Scand J Rheumatol; 2016 Jul; 45(4):299-303. PubMed ID: 26854592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
    Song SH; Hardisty CA
    QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.
    Karlsson SA; Hero C; Svensson AM; Franzén S; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Eliasson B; Andersson Sundell K
    BMJ Open; 2018 Mar; 8(3):e020309. PubMed ID: 29602853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study.
    Wan EYF; Yu EYT; Chin WY; Fung CSC; Fong DYT; Choi EPH; Chan AKC; Lam CLK
    Diabetes Care; 2018 Jun; 41(6):1134-1141. PubMed ID: 29592967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
    Scott R; Best J; Forder P; Taskinen MR; Simes J; Barter P; Keech A;
    Cardiovasc Diabetol; 2005 Aug; 4():13. PubMed ID: 16111499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of cardiovascular diseases and associated risk factors among subjects with type 2 diabetes - an 11-year follow up study.
    Umamahesh K; Vigneswari A; Surya Thejaswi G; Satyavani K; Viswanathan V
    Indian Heart J; 2014; 66(1):5-10. PubMed ID: 24581089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.
    Franzini L; Ardigò D; Cavalot F; Miccoli R; Rivellese AA; Trovati M; Zavaroni I; Vaccaro O
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):235-41. PubMed ID: 22397873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Socioeconomic variation in incidence of primary and secondary major cardiovascular disease events: an Australian population-based prospective cohort study.
    Korda RJ; Soga K; Joshy G; Calabria B; Attia J; Wong D; Banks E
    Int J Equity Health; 2016 Nov; 15(1):189. PubMed ID: 27871298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.
    Brownrigg JR; de Lusignan S; McGovern A; Hughes C; Thompson MM; Ray KK; Hinchliffe RJ
    Heart; 2014 Dec; 100(23):1837-43. PubMed ID: 25095826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes.
    Luk AO; Lau ES; So WY; Ma RC; Kong AP; Ozaki R; Chow FC; Chan JC
    Diabetes Care; 2014; 37(1):149-57. PubMed ID: 24356598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underutilisation of cardiovascular medications among at-risk individuals.
    Lewis SJ; Robinson JG; Fox KM; Grandy S;
    Int J Clin Pract; 2010 Apr; 64(5):604-10. PubMed ID: 19909379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease.
    Hubbard D; Colantonio LD; Rosenson RS; Brown TM; Jackson EA; Huang L; Orroth KK; Reading S; Woodward M; Bittner V; Gutierrez OM; Safford MM; Farkouh ME; Muntner P
    Cardiovasc Diabetol; 2021 Mar; 20(1):58. PubMed ID: 33648518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.